Trinity Life Sciences Introduces New Field Force Impact Benchmarking Service
November 2, 2020Trinity Stakeholder Voice Offers Biopharma Companies Critical Insights into How to Best Serve Healthcare Providers in a New and Changing Reality
WALTHAM, Mass.–(BUSINESS WIRE)–#stakeholdervoice—Trinity Life Sciences, a leader in global life sciences solutions, introduces a new field force impact benchmarking service called Trinity Stakeholder Voice. The service offers critical insights for biopharmaceutical companies looking to lead the market in a new and changing reality.
Stakeholder Voice reveals how healthcare providers really feel about their pharmaceutical sales representatives and/or medical science liaisons. The service allows biopharma companies to benchmark how their frontline teams are doing in terms of outreach frequency and quality of interactions compared to competitors in the same indication. The Trinity-sponsored market research is conducted on the top ten brands in a specific indication. Stakeholder Voice is a bi-annual benchmark of sales representative and/or medical science liaison performance allowing companies to see how frontline interactions evolve over time.
Traditional frontline representative visits to healthcare practices have dramatically changed since COVID-19 and pharma companies need to identify new or updated approaches for these one-on-one conversations. Some companies have adjusted faster than others to this new reality and Trinity Stakeholder Voice helps companies identify what is working well and what is not.
“Now more than ever, in an ever-changing pandemic environment, it is critical that biopharmaceutical companies maximize their interactions with healthcare professionals,” said Neal Dunn, Senior Partner and Head of Insights and Analytics, Trinity. “Trinity Stakeholder Voice reveals the types of interactions that healthcare providers feel add value when prescribing a certain brand. This knowledge allows pharma companies to proactively train their frontline representatives to offer the best service.”
Currently Supported Studies*
- Breast Cancer
- Colorectal Cancer
- Non-small Cell Lung Cancer
- Prostate Cancer
- Rheumatoid Arthritis and Psoriatic Arthritis
- Psoriasis and Atopic Dermatitis
- Crohn’s Disease and Ulcerative Colitis
- Asthma/Chronic Obstructive Pulmonary Disease
- Diabetes
- Multiple Sclerosis
- Headache
- Rare – Cardiologists
- Rare – Neurologists
- Rare – Hematologists
*Additional indications and ex-US geographies are available on request.
About Trinity Life Sciences
Trinity Life Sciences is a trusted strategic partner, providing evidence-based solutions for the life sciences. With over 20 years of experience, Trinity is committed to solving clients’ most challenging problems through exceptional levels of service, powerful tools, and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.
Contacts
Elizabeth Marshall
Trinity Life Sciences
781-577-6376
[email protected]